News | July 19, 2010

Cancer Management Solutions Showcased at 2010 AAPM

Elekta-Synergy

July 19, 2010 – Elekta will showcase its broad array of intelligent solutions for radiation therapy planning, oncology information management and image guided radiation therapy this week at the 2010 American Association of Physicists in Medicine (AAPM) Annual Meeting.

Elekta will also be demonstrating Clarity T, the latest addition to the Elekta product portfolio. Clarity provides non-invasive soft tissue visualization to support radiation therapy workflows. Using latest generation 3-D ultrasound specifically designed for radiation therapy, Clarity compares 3-D structures—not images—to provide accurate guidance non-invasively, without additional dose or any compromise to throughput.

Representing the latest advance in 4-D image guidance, Elekta’s XVI now offers intelligent motion management and guidance. Symmetry T motion management provides imaging tools to manage shifts in the relative positions of the tumor and organs-at-risk during the respiratory cycle. Intuity T provides critical structure avoidance by accounting more accurately for both the position of the tumor and the healthy critical structures.

Elekta also will show the new version of Atlas-based Auto-segmentation (ABAS) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase segmentation accuracy. ABAS deforms atlases of anatomy previously defined on a reference image onto a new patient image, creating a new structure set fit to the patient anatomy and enhancing planning efficiency.

Intelligent planning for Elekta VMAT is also available through Monaco with VMAT, which helps clinicians plan around structures effectively for Elekta VMAT delivery and predict the total dose the patient will receive.

To streamline the entire medical oncology or radiation oncology workflow, Elekta offers the MOSAIQ oncology information system. Through its image-enabled electronic medical record (EMR), MOSAIQ helps centers coordinate information management involving diagnosis and staging, planning, treatment and follow-up.

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res